Psychedelic Drugs: Considerations for Clinical Investigations; Guidance for Industry; Draft Guidance
OtherFDA-2023-D-1987-0002
Comments
0
Awaiting comments
Deadline
Closed on Aug 26, 2023
Closed Aug 26, 2023
Net supportiSupport minus oppose · campaigns included
—
Document
Details
The document's own metadata, straight from the source system.
- Title
- Psychedelic Drugs: Considerations for Clinical Investigations; Guidance for Industry; Draft Guidance
- Posted
- Jun 26, 2023
- Comment period
- Jun 26, 2023 – Aug 26, 2023
Analysis
Overview
No comments yet.
Comments
Explorer
Every mirrored comment — filter by stance, campaign, or issue.
Filter:
No comments match.